Donor lymphocyte infusion followed by interferon-α plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation
- 1 April 2001
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 25 (4) , 353-357
- https://doi.org/10.1016/s0145-2126(00)00143-0
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Successful treatment of relapsed CML after cord blood transplantation with donor leukocyte infusion IL-2 and IFNαBone Marrow Transplantation, 2000
- Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantationBone Marrow Transplantation, 1999
- Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]Blood, 1995
- The interferons. Mechanisms of action and clinical applicationsJAMA, 1991